Related Experiment Video
Updated: Aug 15, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
[Effect of alpha 1 adrenergic stimulation on myocardial relaxation]
P Pedroni1, A Mattiazzi, H E Cingolani
1Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.
Abstract:
The aim of the present study was to elucidate which was the effect of alpha 1 adrenergic stimulation on myocardial relaxation. Experiments were performed in cat papillary muscles contracting isometrically at 12 beats/min. The effect of phenylephrine (P) in the presence of propranolol (10(-6)M) on myocardial relaxation was compared with that produced by a similar increase in myocardial contractility (+T) elicited by increasing extracellular calcium (Ca2+). An increase of 40% in maximal velocity of contraction (+T) produced by P and Ca2+ elicited in both cases a proportional increase in maximal velocity of relaxation (-T). Therefore the +T/-T ratio remained unchanged. At this contractility level relaxation time (Rt) and time to half relaxation (t1/2) were slight by significantly prolonged by P and not changed by Ca2+. When contractility was increased by approximately 200%, both, P and Ca2+ increased by a less extent -T. Consequently +T/-T augmented from 1.21 +/- 0.04 to 1.73 +/- 0.09 (48.3 +/- 9.5%) with P, and from 1.37 +/- 0.04 to 1.77 +/- 0.15 (31 +/- 12%) with Ca2+. Rt was also significantly increased by both interventions: 21.5 +/- 8.8% (Ca2+) and 24.2 +/- 2.68% (P), whereas t1/2 was significantly increased by P from 215 +/- 11 msec to 282 +/- 12 msec (33 +/- 5.8%) but did not change with Ca2+. Prazosin (10(-6)M) antagonized the effects on contractility and relaxation produced by P. The present results thus indicate that the positive inotropic effect of alpha 1 adrenergic stimulation may be characterized by a prolongation of the early relaxation phase, that was not mimicked by a similar increase in myocardial contractility elicited by increasing extracellular calcium.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...

